Sponsored by
Good morning, Founderscrowd community,
Jose here.
Saturday is when we look at the actual capital that closed during the week, not rumors or whispers. This week brought seven significant funding rounds across different sectors that show a crystal clear pattern about what investors actually want right now.
Capital is flowing away from pure AI hype and toward infrastructure that solves real business problems. Let's break down each one.
SPONSORED OF THE DAY
Save 10+ Hours a Week With 37 Claude Prompts
Every manager faces the same situations before lunch: a message to land, a meeting to run, a hiring call, a report due. The AI Report built 37 Claude prompts for exactly those moments, organised by the situations every manager faces.
Copy the prompt, fill the brackets, run it in Claude, and get back 10+ hours a week. Oh, and it's free.
All you have to do is subscribe to The AI Report, a 5-minute daily AI brief read by 400,000+ business leaders at IBM, AWS and Microsoft, and the full prompt pack lands in your welcome email. The newsletter and the prompts, both free. Subscribe and grab both
LATEST DEVELOPMENTS
FUNDRAISING |
1. LEAPXPERT CLOSES $180M (THE BIGGEST) |
Signal: Governed communications software platform just raised the largest single round of the week, $180M led by Riverwood Capital. Previous total raised: $42M. This is a major validation of a category that barely existed five years ago.
Details:
Riverwood Capital led, and Portage Ventures continued backing
Growth investment, not a typical venture round (bigger checks, slower rounds)
Valuation not disclosed but this is clearly a $1B+ company
Jeff Parks from Riverwood is joining the board
Focus: Financial services (proven), government (fastest growing), Forbes Global 2000 (next wave)
Why It Matters: Enterprise conversations happened on email for 20 years. Now they happen on WhatsApp, iMessage, Signal, and WeChat. Companies need governance, compliance, and now AI intelligence from those conversations. LeapXpert sits between business and regulation, governing what employees see and what regulators need to see.
Two patterns: First, infrastructure capital is flowing to governance layers. The conversation-capture-and-govern layer is as essential now as email storage was ten years ago. Second, Riverwood Capital is a specialist in proven growth companies scaling from $50M to $500M revenue. That signal alone says LeapXpert is already substantial and just entering scale mode.
The Play: This is what $180M tells you: Someone thinks LeapXpert is doing $80-150M revenue run rate already. That money buys expansions into Europe, Latin America, Asia, plus deeper AI capabilities. Expect announcements of new verticals and regional hires within three months.
FUNDRAISING |
2. BEELINE MEDICINES CLOSES $126.3M (BIOTECH SCALE) |
Signal: Autoimmune disease company raising late-stage biotech capital, $126.3M Series A extension. Led by Bain Capital and CPP Investments (Canada's largest pension fund). Previous Series A: ~$300M total.
Details:
Series A extension, not a Series B yet (means they want to stay disciplined)
CPP Investments leading signals institutional conviction (patient capital, long-term)
Bain Capital leading signals operational focus (healthcare scaling expertise)
Additional backing from Bristol Myers Squibb, existing management
Headquarters: Stamford CT and Boston MA (biotech corridor confidence)
Why It Matters: This is not a pre-clinical bet. Companies raising $126M extensions on Series A have clinical data. Beeline presumably has proof of concept in autoimmune/inflammatory disease space and now needs capital to accelerate manufacturing and trials.
Why Bain and CPP? Bain knows how to scale biotech operations. CPP Investments has a 20+ year horizon and doesn't panic on quarterly swings. That combination signals this company has a real path to a $10B+ exit and investors who can wait for it.
The Play: Watch for Phase 2 clinical data releases. That's when Beeline becomes either acquisition bait for a pharma company or a standalone exit target. $126M funds 18-24 months of runway on a biotech with credible data.
FUNDRAISING |
3. HIGHARC CLOSES $95M SERIES C (AI FOR EXPENSIVE WORKFLOWS) |
Signal: Homebuilding software raising $95M Series C led by Insight Partners. Total funding to date: $170M+. This is the third time we're seeing this company close capital in two years.
Details:
Insight Partners led (they specialize in enterprise software scale)
Homebuilding design-to-construction AI platform
Series C came with major commercial expansion into new segments
$2+ trillion industry, mostly still manual workflows
Gross margins historically 70-80%+ for software in this category
Why It Matters: Homebuilding is expensive. Design mistakes cost real money. Labor shortages are severe. AI that reduces design iteration time or construction delays has immediate ROI. That's why capital is willing to deploy $95M into vertical AI without hesitation.
This is also the second major signal this week about vertical AI platforms. First Higharc, second LeapXpert. Both solve specific industry problems, not generic challenges. Both saw investor oversubscription. Capital is moving away from "AI for everyone" and toward "AI for X expensive problem in Y industry."
The Play: Higharc will likely announce partnerships with major homebuilders in next 90 days. Commercial expansion means customer concentration is solving. Path to Series D or IPO is now open if execution holds.
PREMIUM
Join Founderscrowd Premium to get:
Unique investment opportunties
Our detailed valuation analysis (why this entry point makes sense)
The specific risks to watch before IPO
How to structure your position ($25K minimum)
Real-time alerts when secondary tranches open
Step-by-step process to invest
Premium members also get first dibs on allocation — the difference between getting in and getting locked out.
This is where founders and serious investors actually allocate capital.
QUICK HITS
WHAT THIS WEEK TELLS YOU
Seven rounds. $527M raised. Clear pattern emerging.
Capital no longer chases pure AI or generic software. It flows toward:
Infrastructure that sits between business and regulation (LeapXpert)
Expensive industries with labor shortages and hard problems (Queue, Higharc, Beeline)
Founders who reach profitability early and stay capital efficient (Qashier)
Specialist investors who know their category (Riverwood in growth software, Insight in enterprise, Bain in biotech)
This is not venture funding as it was in 2021. This is venture funding for founders who solve real problems and who investors believe can scale sustainably.
Hunt accordingly. ☕
Jose.
QUICK NOTE: WHAT TO WATCH NEXT WEEK
Expect announcements from Anduril and OpenAI related to manufacturing expansion and government contracts. Those $5B+ rounds always have follow-up news that hits within 7-10 days.
Also, the second half of the year (July forward) is when Series A and B deals accelerate. Capital that sat on the sidelines in June is deployed. Watch for larger round announcements.
DISCLAIMER
Founderscrowd is an independent financial media.
Nothing here is investment advice. All company information is drawn from public filings, press releases, and news reports. This is not a comprehensive list of all funding that closed this week, only the rounds that represent meaningful capital deployment patterns.
Only invest capital you can afford to lose. Consult qualified advisers before investing.
© 2026 Founderscrowd. All rights reserved.